• Cancer Centers Measure COVID-19 Impact on Clinical Trials

    Clinical Research News | A clinical team at Dana Farber Cancer Institute and Mount Sinai explored oncology clinical trial disruption during the COVID-19 pandemic. They found that substantial disruptions early in the pandemic gradually recovered, but some lasting changes remain.

    Jul 21, 2022

  • Case Series Paves Way For Clinical Trials With Phage Therapy

    Clinical Research News | In collaboration with physicians from around the world, researchers at the University of Pittsburgh and the University of California San Diego School of Medicine recently reported on a series of 20 consecutive cases where an intractable, non-tuberculous Mycobacterium infection was treated with phage therapy over an average course of six months. More than half of those patients saw a favorable clinical or microbiological outcome.

    Jul 19, 2022

  • Milestones Easier To Meet With Integrated Clinical Trials Management System

    Clinical Research News | Until recently, clinical study teams at the Medical University of South Carolina had no system for registering participants, keeping track of upcoming study visits, or what to invoice when on industry-sponsored projects. All that is changing with implementation of a clinical trials management system, fully integrated with the university’s Research Integrated Network of Systems, in mandatory use since March 2022 for all new trials undertaken across campus.

    Jul 14, 2022

  • Tufts Study Provides ‘First Hard Metrics’ Around Decentralized Clinical Trials

    Clinical Research News | Decentralized clinical trials can deliver a higher “expected net present value” that equates to a roughly $10 million return on a $2 million investment for phase 2 trials and $39 million return on a $3 million investment for phase 3 studies. The economic savings come from reduced cycle times, improved patient screening and enrollment, and fewer protocol amendments over the life of a trial.

    Jul 13, 2022